Editorial: in the era of effective antiviral therapy, long‐term dynamic endoscopic monitoring does not seem to be necessary for all CHB patients with compensated cirrhosis

LINKED CONTENT This article is linked to Farina et al paper. To view this article, visit https://doi.org/10.1111/apt.17463

Saved in:
Bibliographic Details
Published inAlimentary pharmacology & therapeutics Vol. 57; no. 12; pp. 1467 - 1468
Main Authors Li, Lan‐Qing, Chen, En‐Qiang
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.06.2023
Subjects
Antiviral agents
Antiviral Agents - therapeutic use
Cirrhosis
Humans
Liver Cirrhosis - diagnosis
Liver Cirrhosis - drug therapy
Online AccessGet full text

Cover

More Information
Summary:LINKED CONTENT This article is linked to Farina et al paper. To view this article, visit https://doi.org/10.1111/apt.17463
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:0269-2813
1365-2036
DOI:10.1111/apt.17487